Interview with Günter Cseh, General Manager, Meda Pharma Austria
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Address: Guglgasse 15/II. Stock, 1110 Vienna,Austria
Tel: +43 + (1) 86390-0
Web: http://www.meda.at/content/home/index.php
Meda is a leading specialty pharmaceutical company in Europe that offers cost-oriented medicine and the medical need. With offices in 26 countries Meda covers almost the whole of Europe. In other world markets, the pharmaceuticals are marketed by Meda and other representatives of pharmaceutical companies and sold.
Meda focuses on the treatment areas asthma & allergies, cardiovascular disease, pain and inflammation, gastroenterology and dermatology & infections.
Meda Pharma GmbH with its headquarters in Vienna (see photo) is a subsidiary of Meda AB., Sweden. Meda Pharma Austria looks back on a long company history, what with the PANCHEMIE HOMBURG found its founding. Subsequently developed into ASTA MEDICA Arzneimittel GmbH, which was renamed in 2002 in VIATRIS Pharma GmbH and since October 2005, owned by the Swedish pharmaceutical company Meda is.
Meda Pharma GmbH Austria continues its focus on products for the therapy and treatment of respiratory diseases (Novolizer ®, Allergodil ®), pain (Adamon ®) for the prevention and treatment of osteoporosis (Maxi-Kalz ®), treatment of cardiovascular disease (Magnosolv ®, Aquaphoril ®) and a specific complication of diabetes mellitus (Thioctacid ®), as well as therapeutic agents for use in the Department of Gynecology (Cyklokapron ® Ftbl., Estrogel ®, Utrogestan ®, Parlodel ®). Another therapeutic area of Meda Pharma, the treatment of skin diseases, such as the actinic keratoses, basal cell carcinomas or genital warts (Aldara ®). The innovative nutritional supplements Longeva ® completes the product range.
Furthermore, there are good pharmacy products such as Ce-soda ®, Histaxin ®, and Kamillosan Travelgum ® and the dietary supplement Osteo-Active ® and Magnofit ® – pellets in the product portfolio of Meda Austria.
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Dr. Christoph Zielinski, head of the organizational unit of the Comprehensive Cancer Center of Vienna (CCC), a representative of the Austrian oncological community, provides an insight into the key activities…
Harald Isemann, chairman of the Vienna Biocenter (VBC) – one of the leading life science hubs in Europe – and Managing Director of the Institute of Molecular Pathology (IMP), a…
Dr. Andreas Windischbauer, president of the Austrian Association of Full-Line Pharmaceutical Wholesalers (PHAGO) discusses the organization’s role within the Austrian pharma industry, its current challenges, price pressures, competition, and future…
Christa Wirthumer-Hoche, head of the Austrian Medicines and Medical Devices Agency (AGES) and chair of the European Medicines Agency (EMA) management board, discusses the role of AGES within Austria, similarities…
Mogens Guldberg, general manager of Novo Nordisk Austria, the Danish global powerhouse focused on innovative diabetic treatments, provides a unique insight into the obstacles associated with launching innovative products in…
Dr. Wolfgang Andiel, president of the Austrian Association of Generic Medicines (OeGV, Österreichischer Generikaverband), which acts as a unified voice to represent generics companies in Austria, provides an in-depth analysis…
Historically, Austria was the dominant political power in Central Europe under the Habsburg dynasty which ruled until World War I. Although the 20th century has been marked by significant shake…
Can you give a brief summary of how Intercell started, how it developed and where it stands today? Intercell was created in 1997 as a spinoff from Vienna University. From…
Let’s start by introducing our readers to the Austrian affiliate of Cegedim. Can you summarize Cegedim scope of activities and operations in Austria, as well as the structure of this…
In your opinion, what have been the most important developments of the healthcare market in Austria over the last three years? To start with, even though we are a national…
Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player with a turnover of…
You have been with Grünenthal since 2004 and as the Austria Country Manager since June 2012. What were your initial goals when you took up the position and how have…
See our Cookie Privacy Policy Here
